Radioactive Drug Research Committee (RDRC)

2020-21 Radioactive Drug Research Committee Charge

This committee provides authorization, surveillance and oversight to the use of radioactive drugs in human subjects. The committee is a subcommittee of, and reports to the Radiation Safety Committee but operates under approval of the Food and Drug Administration (FDA) according to Part 361 of Title 21 of the Code of Federal Regulations.

Meetings will be held as necessary to review and conduct committee business. 

A quorum of this committee, consisting of at least four members, including the Radiation Safety Officer, is necessary to conduct business.

The committee chair shall also serve as an ex officio member of the Radiation Safety Committee.

Committee Chair: Ernest Belezzouli 

Committee Contact: Jeff Wagner

VC RMP Committee Contact: Ashley Chen 

Appoints RepresentativeName DescriptionTermStatus
Ex Officio

Committee On CommitteesErnest Belezzouli (Chair)Radiology/Nuclear Medicine Facultyindefinite CURRENT
Committee on CommitteesCarl HohNuclear Medicine Faculty RepresentativeIndefiniteCURRENT
Committee on CommitteesVacantRadiology Faculty RepresentativeIndefiniteVACANT
Staff AssociationKishore KottaRadiopharmacist Staff RepresentativeIndefiniteCURRENT
Resource Management & PlanningJeff Wagner (Contact)Radiation Safety OfficerIndefiniteCURRENT
Resource Management & PlanningScott LangfordAlternate Radiation Safety OfficerIndefiniteCURRENT